283 related articles for article (PubMed ID: 31639215)
1. Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation.
Letourneau JM; Wald K; Sinha N; Juarez-Hernandez F; Harris E; Cedars MI; McCulloch CE; Dolezal M; Chien AJ; Rosen MP
Cancer; 2020 Feb; 126(3):487-495. PubMed ID: 31639215
[TBL] [Abstract][Full Text] [Related]
2. Random start ovarian stimulation for fertility preservation appears unlikely to delay initiation of neoadjuvant chemotherapy for breast cancer.
Letourneau JM; Sinha N; Wald K; Harris E; Quinn M; Imbar T; Mok-Lin E; Chien AJ; Rosen M
Hum Reprod; 2017 Oct; 32(10):2123-2129. PubMed ID: 28938748
[TBL] [Abstract][Full Text] [Related]
3. Long-Term Safety of Letrozole and Gonadotropin Stimulation for Fertility Preservation in Women With Breast Cancer.
Kim J; Turan V; Oktay K
J Clin Endocrinol Metab; 2016 Apr; 101(4):1364-71. PubMed ID: 26751194
[TBL] [Abstract][Full Text] [Related]
4. The impact of fertility preservation on the timing of breast cancer treatment, recurrence, and survival.
Greer AC; Lanes A; Poorvu PD; Kennedy P; Thomas AM; Partridge AH; Ginsburg ES
Cancer; 2021 Oct; 127(20):3872-3880. PubMed ID: 34161610
[TBL] [Abstract][Full Text] [Related]
5. Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy.
Chien AJ; Chambers J; Mcauley F; Kaplan T; Letourneau J; Hwang J; Kim MO; Melisko ME; Rugo HS; Esserman LJ; Rosen MP
Breast Cancer Res Treat; 2017 Aug; 165(1):151-159. PubMed ID: 28503722
[TBL] [Abstract][Full Text] [Related]
6. Risk of recurrence and pregnancy outcomes in young women with breast cancer who do and do not undergo fertility preservation.
Wang Y; Tesch ME; Lim C; Xu YH; Lee S; Perdizet K; Yokom D; Warner E; Roberts J; Lohrisch CA
Breast Cancer Res Treat; 2022 Sep; 195(2):201-208. PubMed ID: 35908122
[TBL] [Abstract][Full Text] [Related]
7. Controlled ovarian stimulation outcomes of fertility preservation procedures in newly diagnosed breast cancer patients: a retrospective study from a single-tertiary-IVF centre.
Sahin G; Goker ENT; Gokmen E; Yeniay L; Acet F; Zekioglu O; Tavmergen E
J Obstet Gynaecol; 2022 Apr; 42(3):518-523. PubMed ID: 34382483
[TBL] [Abstract][Full Text] [Related]
8. Ovarian stimulation for oocyte vitrification does not modify disease-free survival and overall survival rates in patients with early breast cancer.
Muñoz E; Domingo J; De Castro G; Lorenzo I; García-Velasco JA; Bellver J; Pellicer A; Garrido N
Reprod Biomed Online; 2019 Nov; 39(5):860-867. PubMed ID: 31564650
[TBL] [Abstract][Full Text] [Related]
9. Elective and Onco-fertility preservation: factors related to IVF outcomes.
Cobo A; García-Velasco J; Domingo J; Pellicer A; Remohí J
Hum Reprod; 2018 Dec; 33(12):2222-2231. PubMed ID: 30383235
[TBL] [Abstract][Full Text] [Related]
10. The role of postmastectomy radiation therapy after neoadjuvant chemotherapy in clinical stage II-III breast cancer patients with pN0: a multicenter, retrospective study (KROG 12-05).
Shim SJ; Park W; Huh SJ; Choi DH; Shin KH; Lee NK; Suh CO; Keum KC; Kim YB; Ahn SD; Kim SS; Ha SW; Chie EK; Kim K; Shin HS; Kim JH; Lee HS
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):65-72. PubMed ID: 24161425
[TBL] [Abstract][Full Text] [Related]
11. Similar in vitro maturation rates of oocytes retrieved during the follicular or luteal phase offer flexible options for urgent fertility preservation in breast cancer patients.
Grynberg M; Poulain M; le Parco S; Sifer C; Fanchin R; Frydman N
Hum Reprod; 2016 Mar; 31(3):623-9. PubMed ID: 26759139
[TBL] [Abstract][Full Text] [Related]
12. Survey of young women with breast cancer to identify rates of fertility preservation (FP) discussion and barriers to FP care.
Sauerbrun-Cutler MT; Pandya S; Recabo O; Raker C; Clark MA; Robison K
J Assist Reprod Genet; 2023 Aug; 40(8):2003-2011. PubMed ID: 37329421
[TBL] [Abstract][Full Text] [Related]
13. Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer.
Sonigo C; Amsellem N; Mayeur A; Laup L; Pistilli B; Delaloge S; Eustache F; Sifer C; Rakrouki S; Benoit A; Peigné M; Grynberg M
Fertil Steril; 2023 Mar; 119(3):465-473. PubMed ID: 36473609
[TBL] [Abstract][Full Text] [Related]
14. Value of early referral to fertility preservation in young women with breast cancer.
Lee S; Ozkavukcu S; Heytens E; Moy F; Oktay K
J Clin Oncol; 2010 Nov; 28(31):4683-6. PubMed ID: 20876425
[TBL] [Abstract][Full Text] [Related]
15. Timing of fertility preservation procedures in a cohort of female patients with cancer.
Jenninga E; Louwe LA; Peters AA; Nortier JW; Hilders CG
Eur J Obstet Gynecol Reprod Biol; 2012 Feb; 160(2):170-3. PubMed ID: 22137982
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of preimplantation genetic testing for aneuploidy in medically indicated fertility preservation.
Blakemore JK; Trawick EC; Grifo JA; Goldman KN
Fertil Steril; 2020 Feb; 113(2):408-416. PubMed ID: 31973902
[TBL] [Abstract][Full Text] [Related]
17. Prognostic assessment of breast carcinoma submitted to neoadjuvant chemotherapy with pathological non-complete response.
Resende U; Cabello C; Ramalho SOB; Zeferino LC
BMC Cancer; 2019 Jun; 19(1):601. PubMed ID: 31208353
[TBL] [Abstract][Full Text] [Related]
18. Fertility Preservation in Young Women with Breast Cancer: Impact on Treatment and Outcomes.
Crown A; Muhsen S; Sevilimedu V; Kelvin J; Goldfarb SB; Gemignani ML
Ann Surg Oncol; 2022 Sep; 29(9):5786-5796. PubMed ID: 35672625
[TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of controlled ovarian hyperstimulation for fertility preservation in women with early breast cancer: a systematic review.
Rodgers RJ; Reid GD; Koch J; Deans R; Ledger WL; Friedlander M; Gilchrist RB; Walters KA; Abbott JA
Hum Reprod; 2017 May; 32(5):1033-1045. PubMed ID: 28333356
[TBL] [Abstract][Full Text] [Related]
20. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
